GD vs SCNI · P/E 22, rev $52.55B vs P/E 0.2, rev $1.3M
General Dynamics Corporation (GD) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
GD currently screens at market cap $93.69B and trailing P/E 21.8. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the GD and SCNI stock pages for the full models.
Not investment advice.